**Question:** Prenatal diagnosis of Hemophilia is best done by -

A. Amniocentesis
B. Chorionic villus sampling (CVS)
C. Nuchal translucency measurement
D. Serum factor VIII assay

**Core Concept:**
Hemophilia is a group of inherited bleeding disorders caused by a deficiency in clotting factors. In the case of Hemophilia A, it is a deficiency in Factor VIII, while Hemophilia B is associated with Factor IX deficiency. Prenatal diagnosis is crucial to prevent affected babies from being born to unaffected parents.

**Why the Correct Answer is Right:**
A. Amniocentesis: Amniocentesis is a procedure where a small sample of amniotic fluid is collected from the uterus during pregnancy. This fluid contains fetal cells, including lymphocytes, which can be utilized to test for specific genetic disorders, such as Hemophilia. By analyzing the fetal DNA, one can detect the presence of mutated genes responsible for Hemophilia.

B. Chorionic villus sampling (CVS): CVS is another invasive prenatal diagnostic procedure where samples of chorionic villi (tiny branches of the placenta) are collected for genetic testing. Similar to amniocentesis, it allows testing for genetic disorders, including Hemophilia.

**Why Each Wrong Option is Incorrect:**
C. Nuchal translucency measurement: This is a non-invasive ultrasound measurement used to assess fetal nuchal translucency, a marker for chromosomal abnormalities and some genetic disorders. It is not specifically designed for detecting Hemophilia and is not as reliable as invasive procedures like amniocentesis or CVS.

D. Serum factor VIII assay: This is a test that measures the level of Factor VIII in a patient's blood. It is not suitable for prenatal diagnosis as it solely evaluates the mother's Factor VIII levels, not the fetus's. The correct method involves directly testing the fetal DNA.

**Clinical Pearl:**
Invasive prenatal diagnostic procedures like amniocentesis and CVS allow direct testing of fetal DNA, offering a definitive diagnosis of genetic disorders like Hemophilia. These methods can identify the presence of mutated genes responsible for Hemophilia, enabling couples at risk of transmitting the disorder to their child to make informed decisions about continuing the pregnancy or to prepare for a child with a known genetic condition.